An email interview with the Co-CEO’s of Evidation Health Over the last few weeks I’ve been conducting a back & forth email interview with Christine Lemke (L) & Deb Kilpatrick (R), the co-CEOs of Evidation Health. They raised $153 million in a Series E back… Read More »What’s the Latest with Evidation Health?
The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response. Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated. Over the… Read More »Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity
Evidation, launched as a research app where people can opt into virtual clinical trials, plans to turn some of those insights into digital health programs. The company recently raised $153 million in new funding.
What You Should Know: – Evidation Health announced it has raised $153 million in Series E funding co-led by OMERS Growth Equity and Kaiser Permanente Group Trust. Existing investors including McKesson Ventures and B Capital also joined. – Founded in 2012, Evidation measures health in… Read More »Evidation Health Nabs $153M to Expand Virtual Health Programs